GSK-3beta inhibitor 23 (Compound 11726169) is the inhibitor for glycogen synthase kinase-3, that inhibits GSK-3beta and GSK-3alpha with IC50 of 12.1 nM and 18.8 nM. GSK-3beta inhibitor 23 exhibits antiviral activity against HIV 1. GSK-3beta inhibitor 23 exhibits good metabolic stablility in mouse/human liver microsomes and plasma, but poor Caco-2 permeability (which predicts low oral bioavailability)[1].
Molekulargewicht:
434.30
Formel:
C18H13Cl2N5O2S
Target-Kategorie:
GSK-3
Anwendungsbeschreibung:
MCE Product type: Reference compound
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten
